Evaluation of a Microprocessor-controlled Prosthetic Knee-ankle System (SPCM)
SPCM
1 other identifier
interventional
12
1 country
4
Brief Summary
The main aim of this study is to compare the adaptation capabilities of the microprocessor-controlled knee-ankle prosthesis system with the comparator covered by the French LPPR, known as the "usual prosthesis". The main hypothesis being that wearing the SPCM increases the time spent flat-footed in the various walking situations of everyday life, bringing it closer to that of asymptomatic people. This is a prospective, multicenter, randomized, cross-over study. The participants are transfemoral amputees who have been fitted with a microprocessor-controlled prosthetic knee for more than 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jul 2018
Longer than P75 for not_applicable
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 9, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 19, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedFirst Submitted
Initial submission to the registry
July 16, 2024
CompletedFirst Posted
Study publicly available on registry
July 26, 2024
CompletedJuly 26, 2024
July 1, 2024
4.8 years
July 16, 2024
July 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Comparison of the time (measured as a percentage of the gait cycle) when the foot is flat on the ground during walking in three gait situations: flat, on a slope and going down stairs, with SPCM and the usual prosthesis.
The aim is to compare the adaptation of the prosthetic system to the constraints of everyday life. SPCM adapts the ankle's behavior to the walking situation, and should make it possible to restore the time during which the foot remains flat during the stance phase, in different situations
Evaluation after 4 weeks' wear of each of the 2 prostheses
Secondary Outcomes (9)
Contralateral ankle power
Evaluation after 4 weeks' wear of each of the 2 prostheses
Pelvis elevation
Evaluation after 4 weeks' wear of each of the 2 prostheses
Toe clearance
Evaluation after 4 weeks' wear of each of the 2 prostheses
Prosthesis evaluation
Evaluation after 4 weeks' wear of each of the 2 prostheses
Locomotor abilities
Evaluation after 4 weeks' wear of each of the 2 prostheses
- +4 more secondary outcomes
Study Arms (2)
SPCM
EXPERIMENTALPatients will be fitted with the SPCM prothesis
Usual Prosthesis
ACTIVE COMPARATORPatients will be fitted with their usual microprocessor prosthesis
Interventions
During a period of 4-6 weeks, patients will live in their usual environment with the SPCM prosthesis
During a period of 4-6 weeks, patients will live in their usual environment with their usual microprocessor prosthesis
Eligibility Criteria
You may qualify if:
- Amputee at or above knee level
- Person fitted for more than 3 months with a microprocessor-controlled knee support phase and oscillating phase, in accordance with the conditions for reimbursement set out in the LPPR.
- Person with a level of activity according to the International Classification of of Functioning, Disability and Health greater than or equal to d4602 (moving around outside the house and other buildings)
- Person able to understand simple commands, to read and write, and to give their informed consent
- Person who has given informed consent
- Person affiliated to a social security scheme
You may not qualify if:
- Minor
- Person of full age subject to a legal protection measure or unable to express consent
- Pregnant or breast-feeding women
- Persons with bilateral amputations
- Person with a neurological or orthopedic pathology with major repercussions on locomotion
- Persons with a ground/knee height of less than 43.5 cm or more than 55 cm
- Persons weighing more than 125 kg
- Foot size less than 24 cm or greater than 30 cm
- Person with a hip disarticulation
- Person without an emergency walking solution
- Person with a suspension fitting with vacuum pump
- Person planning a trip outside Europe or unable to return in less than 24 hours (in case of device failure) for the duration of the protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institution Nationale des Invalideslead
- Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Estcollaborator
- Hopital d'instruction des armées Percy (HIA Percy)collaborator
- Proteor Groupcollaborator
- Direction Générale de l'Armementcollaborator
Study Sites (4)
Hôpital d'Instruction des Armées (HIA) Percy
Clamart, 92140, France
UGECAM-NE - Institut Régional de Médecine Physique et de Readaptation de Nancy
Nancy, 54000, France
Insitution Nationale des Invalides
Paris, 75007, France
Institut de Biomécanique Humaine Georges Charpak
Paris, 75013, France
MeSH Terms
Conditions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2024
First Posted
July 26, 2024
Study Start
July 9, 2018
Primary Completion
April 19, 2023
Study Completion
May 31, 2023
Last Updated
July 26, 2024
Record last verified: 2024-07
Data Sharing
- IPD Sharing
- Will not share